| Phase 1 | 1 | |
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT07559864 | Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With… | GIST - Gastrointestinal Stromal Tumor | Recruiting | 2026-04-30 |
| Phase 1 | ||||
| NCT06838338 | JAB-21822 Combined With Chemotherapy and Bevacizumab in Second-line KRAS G12C CRC | Colorectal Cancer | Active, Not Recruiting | 2026-01-08 |